Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
TerminatedNCT00211562
Official study titleReduction of Body Weight in Olanzapine Treated Schizophrenia Patients by Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids
This study ended early.
In AugustaSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Augusta University
CompletedNCT02577575
Official study titleThe Effects of Oxytocin on Social Cognition in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- University of California, San Francisco
CompletedNCT02567032
Official study titleMechanisms and Effects of Oxytocin on Social Cognition in Schizophrenia - Behavioral
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- University of California, San Francisco
CompletedNCT02566356
Official study titleMechanisms and Effects of Oxytocin on Social Cognition in Schizophrenia - fMRI
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaMedication studyAges 18–50
- Countries
- United States
- Sponsor
- University of California, San Francisco
CompletedNCT02621983
This study has finished and is no longer accepting participants.
In DecaturSchizophreniaBehavioural studyAges 18–70
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)
TerminatedNCT00794963
Official study titleAggressive Treatment of Metabolic Syndrome in Patients Treated With Clozapine for Schizophrenia
This study ended early.
In Glen OaksSchizophreniaMedication studyAges 19–79
- Countries
- United States
- Sponsor
- Northwell Health
WithdrawnNCT01567124
Official study titleA Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
This study was withdrawn before enrollment.
Multiple locations, including BallaratSchizophreniaMedication studyAges 18–65
- Countries
- Australia
- Sponsor
- Baker Heart and Diabetes Institute
CompletedISRCTN68824876
About this title
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
Read the official source — NCT01246232Official study titleAmisulpride Augmentation in Clozapine-unresponsive Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including LondonSchizophreniaDrug
- Countries
- United Kingdom
- Sponsor
- Imperial College London
CompletedNCT02130596
About this title
An Acceptance-Based Behavioral Intervention vs. Nutritional Counselling for Weight Loss in Psychotic Illness
Read the official source — NCT02130596Official study titleA Pilot Study of an Acceptance-Based Behavioral Intervention Versus Nutritional Counseling for Weight Loss in Psychotic Illness
This study has finished and is no longer accepting participants.
In TorontoSchizophreniaBehavioural studyAges 18–70
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT03865186
Official study titleAn Evaluation of a Psychoeducation Program for Emotion Identification and Expression in Individuals Diagnosed With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaBehavioural studyAges 18–60
- Countries
- Sponsor
- Kırıkkale University
TerminatedNCT00412620
What is this study about?Researchers are comparing ABT-925 and placebo to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including AnaheimSchizophreniaMedication studyAges 18–65
- Countries
- United States, Argentina, Mexico
- Sponsor
- Abbott
TerminatedNCT05741502
Official study titleAn Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine Versus Non-Clozapine Antipsychotics in Individuals With Treatment-resistant Schizophrenia
This study ended early.
In ColumbusSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Ohio State University